Health care resource utilization and health care costs among digital weight‐loss intervention participants and nonparticipants
Authors' conclusion
Compared to matched nonparticipants, Noom participation was associated with lower HRU, health care costs, and GLP-1 agonist use at 6 months post index. Results of this study support Noom as a cost-effective and HRU-lowering digital weight-management program for working adults in the United States.
Study context
- Population
- Working US adults offered Noom Weightmatched cohort
- Participants
- 723 vs 723
- Exposure
- Noom Weight participation vs offered but not enrolled
- Noomn = 723
- Non-Noomn = 723reference
- Outcome
- HRU, health care costs and GLP-1 agonist use
- Follow-up
- 6 months post index
Methodological detailspropensity-score matched, insurance claims data
- Propensity-score matched
- Insurance claims data
Main finding
As reported in the abstract
- Fewer with Noom
- difference 3.2 outpatient visits; all p values <0.001
- Fewer with Noom
- difference 0.34 ED visits; all p values <0.001
- Fewer with Noom
- difference 0.25 inpatient visits; all p values <0.001
- Fewer with Noom
- difference 0.012 surgeries; all p values <0.001
- Lower with Noom
- difference $831 health care costs
- Fewer with Noom
- difference 42% claims for GLP-1 agonists; P = 0.02
Observational data: associations, not effects.
Original publication
Health care resource utilization and health care costs among digital weight‐loss intervention participants and nonparticipants. Obesity (Silver Spring). Published 14 August 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →